Having been invested in another small mkt-cap bio-tech company for many years, with brilliant products, but a very clear under-performance in product recognition, I am very pleasantly surprised by OSX's geographic penetration. Half of the battle with these bio-techs is getting market penetration amongst a fundamentally conservative industry, slow to adopt new technologies:
This makes its $25 million dollar cap look a little silly.....
Ann: OSX Expands to Latin America with Initial Sales to Colombia, page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.692M | |||
| Open | High | Low | Value | Volume |
| 1.4¢ | 1.4¢ | 1.3¢ | $18.51K | 1.360M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 391872 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.5¢ | 1193519 | 5 |
View Market Depth
| Last trade - 11.10am 22/07/2025 (20 minute delay) ? |
| OSX (ASX) Chart |